HCID 86715162, compound → HCID 136408076, compound
Reaction equation
[CH3:1][C:2]1[S:6][C:5]2[NH:7][C:8]3[CH:9]=[CH:10][CH:11]=[CH:12][C:13]=3[N:14]=[C:15]([N:16]3[CH2:21][CH2:20][N:19]([CH3:22])[CH2:18][CH2:17]3)[C:4]=2[CH:3]=1.[CH:23]([NH:26][C:27](=[O:31])[O:28][CH2:29][I:30])([CH3:25])[CH3:24]>C(#N)C>[I-:30].[CH:23]([NH:26][C:27]([O:28][CH2:29][N+:19]1([CH3:22])[CH2:20][CH2:21][N:16]([C:15]2[C:4]3[CH:3]=[C:2]([CH3:1])[S:6][C:5]=3[NH:7][C:8]3[CH:9]=[CH:10][CH:11]=[CH:12][C:13]=3[N:14]=2)[CH2:17][CH2:18]1)=[O:31])([CH3:25])[CH3:24]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of Olanzapine, (2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine)[4134] (0.025 g, 0.086 mmol, 1.0 eq) in ACN was added iodomethyl isopropylcarbamate [6318] (0.20 g, 0.086 mmol, 1.0 eq) at RT. The reaction mixture was stirred at RT for four to 16 h. Reaction progress was monitored by TLC. Solvent was removed under vacuum to get a crude product. The crude product obtained was triturated with diethyl ether (5 ml×2) to give the desired product [294], 1-(((isopropylcarbamoyl)oxy)methyl)-1-methyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide (0.013 g, 41%) as yellow solid.
Workup
- customReaction progress
- customSolvent was removed under vacuum
- customto get a crude product
- customThe crude product obtained
- customwas triturated with diethyl ether (5 ml×2)
Sources & evidence
- ORD record
- ord-0c10b6a73dc9461ea858691ab29ac378
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09359376B2
Reaction notes
Loading…